EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical features, biomarker profiles, and neuroimaging characteristics in patients from memory clinic in china: The Shanghai Memory Study

Jie Wang, Xiaoxi Ma, Jiaying Lu, Jie Wu, Zhenxu Xiao, Huiwei Zhang, Weiqi Bao, Saineng Ding, Li Zheng, Xiaoniu Liang, Yihui Guan, Chuantao Zuo und 3 weitere

Alzheimer's & Dementia · 2025

DOI: 10.1002/alz.70378 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Jie Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department and Institute of Neurology, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Alzheimer Disease, Neuroimaging. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Ministry of Science and Technology, Shanghai Municipal Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Despite advances in biomarker assessment, molecular neuroimaging, and disease‐modifying therapies for cognitive disorders, China lacks well‐characterized clinical cohorts integrating comprehensive clinical assessments and multimodal biomarkers. METHODS The Shanghai Memory Study (SMS), an ongoing hospital‐based cohort, enrolled participants undergoing clinical/neuropsychological assessments, genotyping, multimodal imaging, and biospecimen collection. RESULTS From 2012 to 2024, 2001 participants were enrolled: 115 cognitively unimpaired (CU), 938 with mild cognitive impairment (MCI), and 948 with dementia. Positron emission tomography (PET) scan revealed A+/T+ positivity rates of 15.8% in CU, 51.2% in MCI, and 100% in Alzheimer's disease dementia (ADD). Plasma tau phosphorylated at threonine 181 (p‐tau181) level increased gradually across the AD continuum. Blood p‐tau181 and 18F‐Florzolotau PET showed comparable utility for amyloid status identification. In a subcohort of 251 amnestic MCI (aMCI) patients, low Aβ42/Aβ40 and elevated p‐tau181 predicted 4.7‐year ADD risk. DISCUSSION By offering an integrated framework, SMS will facilitate the exploration of AD pathogenesis and the understanding of cognitive disorders. Highlights The SMS is an ongoing prospective cohort study based on a memory clinic in China. The SMS has established a relatively large‐scale dataset that includes clinical data, biofluid markers, MRI and PET imaging, and novel biomarkers. By offering an integrated framework, SMS aims to facilitate the exploration of AD pathogenesis and deepen our understanding of cognitive disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionAlzheimer DiseaseNeuroimagingHumansChinaMaleFemaleBiomarkerstau ProteinsAgedPositron-Emission TomographyAmyloid beta-PeptidesNeuropsychological TestsMiddle AgedCohort StudiesBrain

Stichwörter der Autor:innen

Alzheimer's diseasebiomarkerdementiaepidemiologyhospital‐based studyneuroimaging

Substanzen

Biomarkerstau ProteinsAmyloid beta-Peptides

Autor:innen und Institutionen

  • Department and Institute of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
  • Department of Nuclear Medicine and PET Center, Huashan Hospital, Fudan University, Shanghai, China.
  • National Center for Neurological Disorders, Huashan Hospital, Fudan University, Shanghai, China.
  • National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China.
  • MOE Frontiers Center for Brain Science, Fudan University, Shanghai, China.

Förderung

  • National Natural Science Foundation of China
  • National Ministry of Science and Technology
  • Shanghai Municipal Science and Technology Major Project

Zitieren

APA

Wang, J., Ma, X., Lu, J., Wu, J., Xiao, Z., Zhang, H., Bao, W., Ding, S., Zheng, L., Liang, X., Guan, Y., Zuo, C., Ding, D., Zhao, Q., & Shanghai Memory Study (SMS) (2025). Clinical features, biomarker profiles, and neuroimaging characteristics in patients from memory clinic in china: The Shanghai Memory Study. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70378

Vancouver

Wang J, Ma X, Lu J, Wu J, Xiao Z, Zhang H, et al. Clinical features, biomarker profiles, and neuroimaging characteristics in patients from memory clinic in china: The Shanghai Memory Study. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70378

BibTeX
@article{Wang2025,
  author = {Wang, Jie and Ma, Xiaoxi and Lu, Jiaying and Wu, Jie and Xiao, Zhenxu and Zhang, Huiwei and Bao, Weiqi and Ding, Saineng and Zheng, Li and Liang, Xiaoniu and Guan, Yihui and Zuo, Chuantao and Ding, Ding and Zhao, Qianhua and Shanghai Memory Study (SMS), Shanghai Memory Study (SMS)},
  title = {Clinical features, biomarker profiles, and neuroimaging characteristics in patients from memory clinic in china: The Shanghai Memory Study},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  doi = {10.1002/alz.70378}
}
Kostenlos starten →